Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2205299/novo-nordisk-nvo-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2205299
Jan 03, 2024 - In the closing of the recent trading day, Novo Nordisk (NVO) stood at $103.62, denoting a +1.48% change from the preceding trading day.
0
Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold
https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/?source=iedfolrf0000001
Jan 03, 2024 - The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead.
0
Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
https://www.zacks.com/stock/news/2205099/here-s-why-you-should-bet-on-rigel-pharmaceuticals-rigl-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205099
Jan 03, 2024 - Here, we discuss some reasons why buying Rigel Pharmaceuticals (RIGL) stock now may turn out to be a prudent move.
0
Here's Why You Should Invest in Aquestive (AQST) Stock Now
https://www.zacks.com/stock/news/2204853/here-s-why-you-should-invest-in-aquestive-aqst-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204853
Jan 03, 2024 - Here, we discuss some reasons why buying Aquestive Therapeutics (AQST) stock now may turn out to be a prudent move.
0
Top Analyst Reports for Novo Nordisk, Walmart & AMD
https://www.zacks.com/commentary/2202579/top-analyst-reports-for-novo-nordisk-walmart-amd?cid=CS-ZC-FT-research_daily-2202579
Dec 27, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Walmart Inc. (WMT) and Advanced Micro Devices, Inc. (AMD).
0
Why You Should Invest in Encompass Health (EHC) Stock for Now
https://www.zacks.com/stock/news/2202750/why-you-should-invest-in-encompass-health-ehc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202750
Dec 27, 2023 - Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.
0
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
https://www.zacks.com/stock/news/2202279/sarepta-srpt-seeks-label-expansion-for-dmd-gene-therapy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202279
Dec 26, 2023 - Sarepta (SRPT) files a supplement with the FDA seeking to expand its recently-approved gene therapy Elevidys' label to treat all DMD patients, regardless of age and ambulatory status.
0
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
https://www.zacks.com/stock/news/2201716/jazz-pharmaceuticals-jazz-ptsd-drug-misses-study-goals?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201716
Dec 22, 2023 - After a mid-stage study fails to show any improvement in its primary or secondary endpoints, Jazz (JAZZ) plans to scrap the development of its PTSD drug.
0
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
https://www.zacks.com/stock/news/2201156/merck-s-mrk-chronic-cough-drug-gets-another-crl-from-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201156
Dec 21, 2023 - Per the FDA, the data submitted by Merck (MRK) for its chronic cough drug did not provide sufficient evidence to prove its clinical benefit in patients.
0
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/?source=iedfolrf0000001
Dec 21, 2023 - Which weight-loss stocks are good buys today?
0